InvestorsHub Logo
Followers 4
Posts 1277
Boards Moderated 0
Alias Born 07/14/2008

Re: None

Thursday, 10/02/2014 6:27:42 AM

Thursday, October 02, 2014 6:27:42 AM

Post# of 8311
Here is an outstanding summary of the true health of TENX.

http://seekingalpha.com/article/2261763-oxygen-bio-insiders-register-to-exit-as-paid-promoters-hype-stock

It states in part:

1. Orion attempts to file an FDA NDA in the U.S. in 1999, but never succeeds.

2. 2004 Orion and Abbott "expand" marketing relationship.

3. 2006 Abbott says it is "exploring options for next steps in the U.S."

4. 4/27/2007 Abbott "has decided not to continue the development program for the product in the US, because it would not be commercially reasonable."

5. 6 years later, Orion licenses Simdax to a recently founded "company" called Phyxius, apparently made up of 4 guys using a residential address in New Jersey as their headquarters.

6. This same group of individuals then sells this to a floundering biotech company in exchange for $4.8m in stock.

7. Are we to believe that two global pharma juggernauts already spent millions of dollars and apparently years of effort attempting to commercialize this old drug in the U.S., both failed, but a few guys operating from a house in NJ now have a "$600m market opportunity" that they traded for $4.8m in OXBT stock?

8. Milestone payments based on the achievement of market capitalization (i.e. stock price increases!) - also why are licensing terms redacted? Reference details below.

Ah, the smell of salt air
and the touch of gentle winds.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News